Tenon Medical Receives Nasdaq Delisting Notice for Sub-$1.00 Bid Price
TNON sits 35% above its 52-week low of $0.641 on light trading volume (0.1× avg).
Summary
Tenon Medical, Inc. has received a notice from Nasdaq regarding its failure to maintain the minimum $1.00 bid price, initiating a 180-day compliance period to avoid delisting.
Key Events · Legal and Risk Events · TNON
-
Nasdaq Delisting Notice Received
On February 25, 2026, Tenon Medical received a notice from Nasdaq for failing to maintain a minimum closing bid price of $1.00 per share for 30 consecutive business days.
-
180-Day Compliance Period Initiated
The company has until August 24, 2026, to regain compliance by having its common stock close at or above $1.00 for at least 10 consecutive business days.
-
Potential Reverse Stock Split
If compliance is not met within the initial period, the company may be eligible for an additional 180-day period, potentially requiring a reverse stock split to cure the deficiency.
-
No Immediate Effect on Listing
The notice does not immediately affect the listing of TNON common stock, which will continue to trade on The Nasdaq Capital Market under the symbol 'TNON'.
Analysis · TNON · Industrial Applications And Services
This 8-K filing reports a critical development for Tenon Medical, Inc., as it has received a delisting notice from Nasdaq due to its common stock trading below the $1.00 minimum bid price requirement. While the company has 180 calendar days to regain compliance, this notice introduces significant uncertainty and risk for investors. Delisting could severely impact the stock's liquidity and the company's ability to raise capital in the future. The company's recent positive revenue growth (reported on February 6, 2026) is now overshadowed by this existential threat to its Nasdaq listing. Investors should monitor the company's plans to regain compliance, which may include a reverse stock split.
At the time of this filing, TNON was trading at $0.87 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $9.7M. The 52-week trading range was $0.64 to $5.85. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.